IP Library Granted Patent US 9,016,516
Granted Patent B2
US 9,016,516 · App. 13/103,234 · Granted Apr 28, 2015

Pen-type pharmaceutical product dispenser

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,016,516
App. No.
13/103,234
Granted
Apr 28, 2015
Kind
B2
Abstract

Pharmaceutical product dispensers (e.g., in the shape of a common ink pen) are operable to indicate information regarding a dosing schedule of a pharmaceutical product dispensable from the dispenser. Embodiments of the dispensers may include a plurality of dosing segments, each corresponding to a different dose of the pharmaceutical product. Actuation of an actuator may result in interaction between the actuator and the pharmaceutical product storage area such that a dose of pharmaceutical product contained in the pharmaceutical product storage area is dispensed, along with a corresponding advancement of the plurality of dosing segments. The dispenser may also include one or more locks to prevent unauthorized access to the pharmaceutical product (e.g., by a child or the like). Furthermore, the pharmaceutical product dispenser may include a disabling mechanism to permanently disable actuation of the actuator of the dispenser.

Claims (56)

1. A pharmaceutical product dispenser, comprising:

an elongated housing comprising a pharmaceutical product storage area located within an interior of said elongated housing, first dosing information on an exterior of said elongated housing, and second dosing information on said exterior of said elongated housing, wherein said elongated housing comprises first and second window segments that are spaced from one another, wherein said first dosing information is disposed adjacent to said first window segment, and wherein said second dosing information is disposed adjacent to said second window segment;

an actuator that interacts with said pharmaceutical product storage area and that is successively actuatable, wherein each actuation of said actuator is a movement of said actuator relative to said elongated housing to dispense a dose from said pharmaceutical product storage area; and

a dosing indicator operatively interconnected with said actuator, wherein said dosing indicator comprises a plurality of dosing segments that each convey dose timing information, wherein adjacent dosing segments are sequentially advanced, by each actuation of said actuator where said actuator is moved relative to said elongated housing, into alignment with a respective one of said first dosing information and said second dosing information on said exterior of said elongated housing, and wherein different said dosing segments of said dosing indicator are simultaneously visible through said first and second window segments, respectively.

2. The pharmaceutical product dispenser of claim 1 , further comprising:

an actuator lock, wherein an axial movement of said actuator is operable to dispense a dose from said pharmaceutical product storage area, wherein a rotational movement of said actuator changes said actuator lock between a locked configuration and an unlocked configuration in relation to said actuator, wherein when said actuator lock is in said locked configuration said actuator lock prevents actuation of said actuator, wherein when said actuator lock is in said unlocked configuration said actuator lock allows actuation of said actuator, wherein rotating said actuator from a first position to a second position and in a first direction disposes said actuator lock in said unlocked configuration, and wherein rotating said actuator from said first position to a third position in a second direction, opposite of said first direction, permanently disposes said actuator lock in said locked configuration.

3. The pharmaceutical product dispenser of claim 1 , wherein said second window segment accommodates a visual indication of at least one of how many doses have been dispensed from said pharmaceutical product storage area and how many doses remain in said pharmaceutical product storage area.

4. The pharmaceutical product dispenser of claim 1 , wherein said second window segment provides visual access to at least part of said pharmaceutical product storage area.

5. The pharmaceutical product dispenser of claim 1 , wherein said second dosing information comprises textual information that conveys a last dose dispensed, and wherein said first dosing information comprises textual information that conveys a next dose to be dispensed.

6. The pharmaceutical product dispenser of claim 1 , wherein each actuation of said actuator advances said dosing indicator one increment.

7. The pharmaceutical product dispenser of claim 1 , wherein said dosing indicator provides a visual indication of a number of doses that have been dispensed from said pharmaceutical product dispenser.

8. The pharmaceutical product dispenser of claim 1 , wherein said actuator is disposed on a first end of said elongated housing, wherein pharmaceutical product is dispensed from a second end of said elongated housing, and wherein said first and second ends are oppositely disposed.

9. The pharmaceutical product dispenser of claim 1 , wherein each actuation of said actuator dispenses a single dose from said elongated housing.

10. The pharmaceutical product dispenser of claim 1 , wherein said actuator is movable into a position where an actuator lock permanently locks said actuator.

11. The pharmaceutical product dispenser of claim 1 , further comprising:

a dispenser lock; and

an actuating mechanism that is spaced from said actuator and that is operatively interconnected with said dispenser lock.

12. The pharmaceutical product dispenser of claim 11 , wherein said actuating mechanism for said dispenser lock and said actuator are positioned relative to one another so as to require one hand to interface with said actuating mechanism and another hand to interface with said actuator.

13. The pharmaceutical product dispenser of claim 11 , wherein said actuating mechanism for said dispenser lock needs to be engaged in order to actuate said actuator.

14. The pharmaceutical product dispenser of claim 11 , wherein said dispenser lock is operatively connected with a discharge opening cover.

15. The pharmaceutical product dispenser of claim 1 , further comprising:

pharmaceutical product within said pharmaceutical product storage area.

16. The pharmaceutical product dispenser of claim 15 , wherein individual doses of said pharmaceutical product are aligned in a row.

17. The pharmaceutical product dispenser of claim 1 , wherein said second dosing information comprises textual information that conveys a last dose dispensed, and wherein said first dosing information comprises textual information that conveys a next dose to be dispensed.

18. The pharmaceutical product dispenser of claim 17 , wherein each said dosing segment of said dosing indicator comprises an icon, wherein said icon for said dosing segment being displayed in said first window segment is blocked, and wherein said icon for each said dosing segment being displayed in said second window segment is visible.

19. The pharmaceutical product dispenser of claim 1 , wherein each said dosing segment of said dosing indicator comprises an icon, wherein said icon for said dosing segment being displayed in said first window segment is blocked, and wherein said icon for each said dosing segment being displayed in said second window segment is visible.

20. A pharmaceutical product dispenser, comprising:

an elongated housing comprising a pharmaceutical product storage area, first dosing information, and second dosing information;

an actuator that interacts with said pharmaceutical product storage area;

an actuator lock, wherein an axial movement of said actuator is operable to dispense a dose from said pharmaceutical product storage area, wherein a rotational movement of said actuator changes said actuator lock between a locked configuration and an unlocked configuration in relation to said actuator, wherein when said actuator lock is in said locked configuration said actuator lock prevents actuation of said actuator, and wherein when said actuator lock is in said unlocked configuration said actuator lock allows actuation of said actuator; and

a dosing indicator operatively interconnected with said actuator, wherein said dosing indicator comprises a plurality of dosing segments, and wherein adjacent dosing segments are sequentially advanced, by actuation of said actuator, into alignment with a respective one of said first dosing information and said second dosing information on said elongated housing.

21. The pharmaceutical product dispenser of claim 20 , wherein rotating said actuator from a first position to a second position and in a first direction disposes said actuator lock in said unlocked configuration, and wherein rotating said actuator from said first position to a third position in a second direction, opposite of said first direction, permanently disposes said actuator lock in said locked configuration.

22. The pharmaceutical product dispenser of claim 20 , wherein said elongated housing comprises a sidewall, wherein said sidewall comprises a window, and wherein at least part of said dosing indicator is visible through said window.

23. The pharmaceutical product dispenser of claim 22 , wherein said window accommodates a visual indication of how many doses remain in said pharmaceutical product storage area.

24. The pharmaceutical product dispenser of claim 20 , wherein each actuation of said actuator dispenses a single dose from said elongated housing, and wherein each actuation of said actuator advances said dosing indicator one increment.

25. The pharmaceutical product dispenser of claim 20 , wherein said second dosing information comprises textual information that conveys a last dose dispensed, and wherein said first dosing information comprises textual information that conveys a next dose to be dispensed.

26. The pharmaceutical product dispenser of claim 20 , further comprising:

a dispenser lock; and

an actuating mechanism that is spaced from said actuator and that is operatively interconnected with said dispenser lock.

27. The pharmaceutical product dispenser of claim 20 , further comprising:

pharmaceutical product within said pharmaceutical product storage area.

28. The pharmaceutical product dispenser of claim 20 , wherein said elongated housing comprises first and second window segments that are spaced from one another, wherein different said dosing segments of said dosing indicator are simultaneously visible through said first and second window segments, respectively, wherein said first dosing information is disposed adjacent to the first window segment on an exterior of said elongated housing, and wherein said second dosing information is disposed adjacent to the second window segment on said exterior of said elongated housing.

29. The pharmaceutical product dispenser of claim 28 , wherein each said dosing segment of said dosing indicator comprises an icon, wherein said icon for said dosing segment being displayed in said first window segment is blocked, and wherein said icon for each said dosing segment being displayed in said second window segment is visible.

30. The pharmaceutical product dispenser of claim 28 , wherein said second dosing information comprises textual information that conveys a last dose dispensed, and wherein said first dosing information comprises textual information that conveys a next dose to be dispensed.

31. The pharmaceutical product dispenser of claim 30 , wherein each said dosing segment of said dosing indicator comprises an icon, wherein said icon for said dosing segment being displayed in said first window segment is blocked, and wherein said icon for each said dosing segment being displayed in said second window segment is visible.

32. A pharmaceutical product dispenser, comprising:

an elongated housing comprising a pharmaceutical product storage area located within an interior of said elongated housing, first dosing information on an exterior of said elongated housing, and second dosing information on said exterior of said elongated housing;

an actuator that interacts with said pharmaceutical product storage area;

a dosing indicator operatively interconnected with said actuator, wherein said dosing indicator comprises a plurality of dosing segments that each convey dose timing information, and wherein adjacent dosing segments are sequentially advanced, by actuation of said actuator, into alignment with a respective one of said first dosing information and said second dosing information on said exterior of said elongated housing; and

an actuator lock, wherein an axial movement of said actuator is operable to dispense a dose from said pharmaceutical product storage area, wherein a rotational movement of said actuator changes said actuator lock between a locked configuration and an unlocked configuration in relation to said actuator, wherein when said actuator lock is in said locked configuration said actuator lock prevents actuation of said actuator, wherein when said actuator lock is in said unlocked configuration said actuator lock allows actuation of said actuator, wherein rotating said actuator from a first position to a second position and in a first direction disposes said actuator lock in said unlocked configuration, and wherein rotating said actuator from said first position to a third position in a second direction, opposite of said first direction, permanently disposes said actuator lock in said locked configuration.

33. A pharmaceutical product dispenser, comprising:

an elongated housing comprising a pharmaceutical product storage area located within an interior of said elongated housing, first dosing information on an exterior of said elongated housing, and second dosing information on said exterior of said elongated housing, wherein said first dosing information conveys prospective dosing information, and wherein said second dosing information conveys retrospective dosing information;

an actuator that interacts with said pharmaceutical product storage area and that is movable relative to said elongated housing, wherein said elongated housing comprises first and second ends that are oppositely disposed from each other, wherein said actuator is moved in a direction of said second end to dispense from said pharmaceutical product storage area, and wherein said second dosing information is located between said first dosing information and said second end of said elongated housing; and

a dosing indicator operatively interconnected with said actuator, wherein said dosing indicator is movable relative to each of said elongated housing, said first dosing information on said elongated housing, and said second dosing information on said elongated housing, wherein said dosing indicator comprises a plurality of dosing segments that move along with said dosing indicator relative to each of said elongated housing, said first dosing information on said elongated housing, and said second dosing information on said elongated housing, wherein each said dosing segment of said plurality of dosing segments conveys dose timing information, and wherein said dosing indicator is advanced relative to said elongated housing by actuation of said actuator to move one said dosing segment into alignment with said first dosing information and to simultaneously move an adjacent said dosing segment into alignment with said second dosing information.

34. The pharmaceutical product dispenser of claim 33 , wherein each said dosing segment of said plurality of dosing segments comprises an icon, wherein said icon for said dosing segment being displayed in conjunction with said first dosing information is blocked, and wherein said icon for said dosing segment being displayed in conjunction with said second dosing information is visible.

35. The pharmaceutical product dispenser of claim 33 , wherein each said dosing segment of said plurality of dosing segments that corresponds with a dispensed dose is visible.

Assignments (14)
RELEASE OF SECURITY INTEREST Recorded Aug 14, 2025
From: ACQUIOM AGENCY SERVICES LLC
To: MALLINCKRODT ENTERPRISES LLC; MALLINCKRODT LLC; MALLINCKRODT PHARMA IP TRADING UNLIMITED COMPANY; MALLINCKRODT PHARMACEUTICALS IRELAND LIMITED; OCERA THERAPEUTICS LLC; SPECGX LLC; STRATATECH CORPORATION; SUCAMPO PHARMA AMERICAS LLC; VTESSE LLC
Reel/Frame 072324/0740 →
INTELLECTUAL PROPERTY SECURITY AGREEMENT Recorded Jul 31, 2025
From: SPECGX LLC
To: WILMINGTON SAVINGS FUND SOCIETY, FSB, AS COLLATERAL AGENT
Reel/Frame 072313/0063 →
RELEASE OF PATENT SECURITY INTERESTS RECORDED AT REEL 060434, FRAME 0536 Recorded Nov 16, 2023
From: DEUTSCHE BANK AG NEW YORK BRANCH, AS COLLATERAL AGENT
To: MALLINCKRODT ENTERPRISES LLC; MALLINCKRODT LLC; SPECGX LLC; OCERA THERAPEUTICS, INC.; STRATATECH CORPORATION; VTESSE LLC; MALLINCKRODT PHARMA IP TRADING UNLIMITED COMPANY; MALLINCKRODT PHARMACEUTICALS IRELAND LIMITED; SUCAMPO PHARMA AMERICAS LLC
Reel/Frame 065601/0347 →
RELEASE OF PATENT SECURITY INTERESTS RECORDED AT REEL 032480, FRAME 0001 Recorded Nov 16, 2023
From: DEUTSCHE BANK AG NEW YORK BRANCH, AS COLLATERAL AGENT
To: THERAKOS, INC.; MALLINCKRODT INTERNATIONAL FINANCE S.A.; MALLINCKRODT CB LLC; MALLINCKRODT FINANCE GMBH; MALLINCKRODT US HOLDINGS LLC (F/K/A MALLINCKRODT US HOLDINGS INC.); MALLINCKRODT CARRIBEAN, INC.; MALLINCKRODT US POOL LLC; MNK 2011 LLC (F/K/A MALLINCKRODT INC.); LUDLOW LLC (F/K/A LUDLOW CORPORATION); CNS THERAPEUTICS, INC.; MALLINCKRODT ENTERPRISES HOLDINGS LLC (F/K/A MALLINCKRODT ENTERPRISES HOLDINGS, INC.); MALLINCKRODT ENTERPRISES LLC; MALLINCKRODT LLC; LAFAYETTE PHARMACEUTICALS LLC; LIEBEL-FLARSHEIM COMPANY LLC; MALLINCKRODT BRAND PHARMACEUTICALS LLC (F/K/A MALLINCKRODT BRAND PHARMACEUTICALS, INC.); MALLINCKRODT VETERINARY, INC.; MALLINCKRODT US HOLDINGS LLC; IMC EXPLORATION COMPANY; MEH, INC.; MALLINCKRODT HOSPITAL PRODUCTS IP UNLIMITED COMPANY (F/K/A MALLINCKRODT HOSPITAL PRODUCTS IP LIMITED); MALLINCKRODT ARD IP UNLIMITED COMPANY (F/K/A MALLINCKRODT ARD IP LIMITED); OCERA THERAPEUTICS LLC (F/K/A OCERA THERAPEUTICS, INC.); SPECGX LLC; STRATATECH CORPORATION; SUCAMPO PHARMA AMERICAS LLC; VTESSE LLC (F/K/A VTESSE INC.); MALLINCKRODT PHARMACEUTICALS IRELAND LIMITED; MALLINCKRODT PHARMA IP TRADING UNLIMITED COMPANY (F/K/A MALLINCKRODT PHARMA IP TRADING D.A.C.); INFACARE PHARMACEUTICAL CORPORATION; ST SHARED SERVICES LLC; IKARIA THERAPEUTICS LLC; INO THERAPEUTICS LLC
Reel/Frame 065609/0322 →
RELEASE OF SECURITY INTERESTS IN PATENTS AT REEL 060389/FRAME 0913 Recorded Nov 15, 2023
From: WILMINGTON SAVINGS FUND SOCIETY, FSB, AS SECOND LIEN COLLATERAL AGENT
To: OCERA THERAPEUTICS LLC (F/K/A OCERA THERAPEUTICS, INC.); MALLINCKRODT LLC; MALLINCKRODT ENTERPRISES LLC; MALLINCKRODT PHARMA IP TRADING UNLIMITED COMPANY; SPECGX LLC; STRATATECH CORPORATION; SUCAMPO PHARMA AMERICAS LLC; VTESSE LLC; MALLINCKRODT PHARMACEUTICALS IRELAND LIMITED
Reel/Frame 065583/0465 →
SECURITY INTEREST Recorded Nov 15, 2023
From: MALLINCKRODT ENTERPRISES LLC; MALLINCKRODT LLC; MALLINCKRODT PHARMA IP TRADING UNLIMITED COMPANY; MALLINCKRODT PHARMACEUTICALS IRELAND LIMITED; OCERA THERAPEUTICS LLC; SPECGX LLC; STRATATECH CORPORATION; SUCAMPO PHARMA AMERICAS LLC; VTESSE LLC
To: ACQUIOM AGENCY SERVICES LLC
Reel/Frame 065595/0376 →
NOTICE OF GRANT OF SECURITY INTEREST IN INTELLECTUAL PROPERTY Recorded Jun 22, 2022
From: MALLINCKRODT ENTERPRISES LLC; MALLINCKRODT LLC; SPECGX LLC; OCERA THERAPEUTICS, INC.; STRATATECH CORPORATION; SUCAMPO PHARMA AMERICAS LLC; VTESSE LLC; MALLINCKRODT PHARMACEUTICALS IRELAND LIMITED; MALLINCKRODT PHARMA IP TRADING UNLIMITED COMPANY
To: DEUTSCHE BANK AG NEW YORK BRANCH
Reel/Frame 060434/0536 →
SECURITY INTEREST Recorded Jun 17, 2022
From: MALLINCKRODT ENTERPRISES LLC; MALLINCKRODT LLC; SPECGX LLC; OCERA THERAPEUTICS, INC.; STRATATECH CORPORATION; SUCAMPO PHARMA AMERICAS LLC; VTESSE LLC; MALLINCKRODT PHARMACEUTICALS IRELAND LIMITED
To: WILMINGTON SAVINGS FUND SOCIETY, FSB, AS SECOND LIEN COLLATERAL AGENT
Reel/Frame 060389/0913 →
RELEASE OF SECURITY INTEREST Recorded Jun 17, 2022
From: WILMINGTON SAVINGS FUND SOCIETY, FSB, AS SECOND LIEN COLLATERAL AGENT
To: OCERA THERAPEUTICS, INC.; MALLINCKRODT LLC; MALLINCKRODT ARD IP UNLIMITED COMPANY (F/K/A MALLINCKRODT ARD IP LIMITED); MALLINCKRODT HOSPITAL PRODUCTS IP UNLIMITED COMPANY (F/K/A MALLINCKRODT HOSPITAL PRODUCTS IP LIMITED); MALLINCKRODT PHARMA IP TRADING UNLIMITED COMPANY (F/K/A MALLINCKRODT PHARMA IP TRADING DESIGNATED ACTIVITY COMPANY); SPECGX LLC; STRATATECH CORPORATION; VTESSE LLC (F/K/A VTESSE INC.)
Reel/Frame 060389/0839 →
SECURITY INTEREST Recorded Dec 10, 2019
From: MALLINCKRODT ARD IP LIMITED; MALLINCKRODT HOSPITAL PRODUCTS IP LIMITED; SPECGX LLC; OCERA THERAPEUTICS, INC.; MALLINCKRODT PHARMA IP TRADING DESIGNATED ACTIVITY COMPANY; STRATATECH CORPORATION; VTESSE INC.; MALLINCKRODT LLC
To: WILMINGTON SAVINGS FUND SOCIETY, FSB, AS SECOND LIEN COLLATERAL AGENT
Reel/Frame 051256/0829 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Dec 13, 2017
From: MALLINCKRODT LLC
To: SPECGX LLC
Reel/Frame 044891/0376 →
SECURITY INTEREST Recorded Mar 19, 2014
From: MALLINCKRODT INTERNATIONAL FINANCE S.A.; MALLINCKRODT CB LLC; MALLINCKRODT FINANCE GMBH; MALLINCKRODT US HOLDINGS INC.; MALLINCKRODT CARIBBEAN, INC.; MALLINCKRODT US POOL LLC; MALLINCKRODT INC.; LUDLOW CORPORATION; CNS THERAPEUTICS, INC.; ENTERPRISES HOLDINGS, INC.; MALLINCKRODT ENTERPRISES LLC; MALLINCKRODT LLC; LAFAYETTE PHARMACEUTICALS LLC; LIEBEL-FLARSHEIM COMPANY LLC; MALLINCKRODT BRAND PHARMACEUTICALS, INC; MALLINCKRODT VETERINARY, INC.; MALLINCKRODT US HOLDINGS LLC; IMC EXPLORATION COMPANY; MEH, INC; MALLINCKRODT ENTERPRISES HOLDINGS, INC.
To: DEUTSCHE BANK AG NEW YORK BRANCH
Reel/Frame 032480/0001 →
CHANGE OF LEGAL ENTITY Recorded Dec 14, 2011
From: MALLINCKRODT INC.
To: MALLINCKRODT LLC.
Reel/Frame 027380/0626 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded May 10, 2011
From: ORTENZI, VERNON D.; ZIEMBA, ROBERT J.; LEWIS, FRANK M.; STROBL, GEOFFREY S.
To: MALLINCKRODT INC.
Reel/Frame 026252/0659 →